Future At Stake, Zafgen Gives First Glimpse of New Obesity Drug Data according to : Xconomy

Future At Stake, Zafgen Gives First Glimpse of New Obesity addiction DataXconomy Boston —Zafgen took a big hit last year when two patient deaths forced it to abandon its most advanced drug, belaronib. The company is now looking to a new experimental weight loss drug for diabetics to turn its fortunes around, with the first glimpse at early data released this afternoon. He expects the weight loss effect will be identical once the drug is tested in a large group of exclusively diabetics. The drug, ZGN-1061, has to prove in much larger, longer studies that it can safely lead to significant weight loss to have a chance to be a commercial product someday. Without percentages, it's impossible to know how significant the weight loss is.




At a session during Digestive Disease Week 2017, held May 6-9 in Chicago, speakers highlighted some new approaches to managing obesity that are now approved by the FDA. In the trial, 90% of participants achieved meaningful weight loss, meaning they shed at least 5% of their original body weight. Although no treatment options for managing obesity are ever going to be perfect, Morton said, the results seen from safe and effective treatments like vBloc demonstrate that weight loss interventions other than surgery can be successful. Pryor ended her talk by discussing how clinicians are undertreating obesity. "This is a major epidemic and we're not doing justice to our patients," she said.

Anthony Comuzzie Named New Executive Director at The Obesity Society

About The Obesity SocietyThe Obesity Society (TOS) is the leading professional society dedicated to better understanding, preventing and treating obesity. "We are pleased to welcome Dr. Comuzzie to The Obesity Society," said TOS President Allen Levine, Ph.D., FTOS. Anthony Comuzzie Named New Executive Director at The Obesity SocietyMonday, May 8, 2017 2:04 PM UTCSilver Spring, Maryland, May 08, 2017 --FOR IMMEDIATE RELEASE: May 8, 2017Silver Spring, MD – Anthony Comuzzie, Ph.D., FTOS, a world-renowned obesity researcher, scientist and co-director of the TOPS Nutrition and Obesity Research Center at Texas Biomedical Research Institute, will serve as the new executive director of The Obesity Society (TOS). Dr. Comuzzie also sat on TOS's Executive Committee as Secretary/Treasurer before accepting the position of executive director. Attachments:A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/e4a8cfb8-477c-4c89-b0f3-21da9e1d1a99Robyn Gordon The Obesity Society 240-485-1951 TOScommunications@obesity.org


collected by :Lucy William

To follow all the new news about Disease !!! All you need to know about all kinds of diseases